1. Home
  2. PHGE vs GVH Comparison

PHGE vs GVH Comparison

Compare PHGE & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GVH
  • Stock Information
  • Founded
  • PHGE 2015
  • GVH 2016
  • Country
  • PHGE Israel
  • GVH Australia
  • Employees
  • PHGE N/A
  • GVH N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GVH
  • Sector
  • PHGE Health Care
  • GVH
  • Exchange
  • PHGE Nasdaq
  • GVH Nasdaq
  • Market Cap
  • PHGE 13.3M
  • GVH 10.8M
  • IPO Year
  • PHGE N/A
  • GVH 2023
  • Fundamental
  • Price
  • PHGE $0.60
  • GVH $0.68
  • Analyst Decision
  • PHGE Strong Buy
  • GVH
  • Analyst Count
  • PHGE 2
  • GVH 0
  • Target Price
  • PHGE $13.50
  • GVH N/A
  • AVG Volume (30 Days)
  • PHGE 126.6K
  • GVH 24.2K
  • Earning Date
  • PHGE 04-02-2025
  • GVH 02-12-2025
  • Dividend Yield
  • PHGE N/A
  • GVH N/A
  • EPS Growth
  • PHGE N/A
  • GVH 12.04
  • EPS
  • PHGE N/A
  • GVH 0.09
  • Revenue
  • PHGE N/A
  • GVH $16,540,178.00
  • Revenue This Year
  • PHGE N/A
  • GVH N/A
  • Revenue Next Year
  • PHGE N/A
  • GVH N/A
  • P/E Ratio
  • PHGE N/A
  • GVH $7.39
  • Revenue Growth
  • PHGE N/A
  • GVH N/A
  • 52 Week Low
  • PHGE $0.48
  • GVH $0.47
  • 52 Week High
  • PHGE $6.30
  • GVH $2.57
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 35.68
  • GVH 45.39
  • Support Level
  • PHGE $0.60
  • GVH $0.66
  • Resistance Level
  • PHGE $0.69
  • GVH $0.74
  • Average True Range (ATR)
  • PHGE 0.11
  • GVH 0.06
  • MACD
  • PHGE -0.04
  • GVH -0.00
  • Stochastic Oscillator
  • PHGE 3.10
  • GVH 16.67

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

Share on Social Networks: